Ruth Arnon
E300536
Ruth Arnon is an Israeli biochemist best known as a co-developer of the multiple sclerosis drug Copaxone and a prominent figure in immunology research.
All labels observed (1)
| Label | Occurrences |
|---|---|
| Ruth Arnon canonical | 2 |
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
Israeli scientist
ⓘ
biochemist ⓘ human ⓘ immunologist ⓘ |
| academicDegree |
MSc in chemistry
ⓘ
PhD in biochemistry ⓘ |
| awardReceived |
AESKU Prize for Life Contribution to Autoimmunity
ⓘ
EMET Prize ⓘ
surface form:
EMET Prize in Life Sciences
Israel Prize ⓘ
surface form:
Israel Prize in Medical Research
Robert Koch Prize ⓘ Rothschild Prize ⓘ
surface form:
Rothschild Prize in Biology
Wolf Prize ⓘ
surface form:
Wolf Prize in Medicine
|
| coDeveloperOf | Copaxone ⓘ |
| collaboratedWith |
Dvora Teitelbaum
ⓘ
Michael Sela ⓘ |
| countryOfCitizenship | Israel ⓘ |
| dateOfBirth | 1933-06-01 ⓘ |
| developedDrugFor | multiple sclerosis ⓘ |
| doctoralAdvisor | Michael Sela ⓘ |
| educatedAt | Hebrew University of Jerusalem ⓘ |
| employer | Weizmann Institute of Science ⓘ |
| familyName | Arnon ⓘ |
| fieldOfWork |
biochemistry
ⓘ
immunology ⓘ multiple sclerosis research ⓘ |
| gender | female ⓘ |
| givenName | Ruth ⓘ |
| hasPublicationType |
review article
ⓘ
scientific article ⓘ |
| knownFor |
co-development of Copaxone
ⓘ
research on multiple sclerosis ⓘ research on synthetic antigens ⓘ |
| languageSpoken |
English
ⓘ
Hebrew ⓘ |
| memberOf |
American Academy of Arts and Sciences
ⓘ
American Philosophical Society ⓘ European Molecular Biology Organization ⓘ Israel Academy of Sciences and Humanities ⓘ |
| name | Ruth Arnon self-link ⓘ |
| notableWork | development of synthetic copolymer 1 (glatiramer acetate) ⓘ |
| placeOfBirth | Tel Aviv ⓘ |
| positionHeld |
Head of Department of Chemical Immunology at Weizmann Institute of Science
ⓘ
President of the Israel Academy of Sciences and Humanities ⓘ Professor at Weizmann Institute of Science ⓘ Vice President of Weizmann Institute of Science ⓘ |
| researchInterest |
autoimmune diseases
ⓘ
synthetic polymers as antigens ⓘ vaccine development ⓘ |
| workplace | Weizmann Institute of Science ⓘ |
Referenced by (2)
Full triples — surface form annotated when it differs from this entity's canonical label.